ANIK Anika Therapeutics, Inc.: Operating Margin

Corporate emblem and logo of Anika Therapeutics Inc. (ANIK)

Under the leadership of Cheryl Blanchard, Anika Therapeutics management is optimizing assets to scale its regenerative segment. Revenues are based on the sale of high-margin hyaluronic acid products. The operating profitability trajectory on the GURU.Markets terminal chart confirms the model's resilience, with the current figure standing at -2.10. Technological development is driven by close collaboration with surgeons and sports medicine centers.

ANIK: Anika Operating Margin 07/04/2022 - 11/20/2026

Anika Therapeutics Inc. - analytical breakdowns and key metrics (ANIK)

- share price and consensus valuation forecast:
Fundamental company analysis:ANIK, Anika Therapeutics, Inc.
Brand item of Anika Therapeutics, Inc.

Operating margin measures the share of profit from core business operations before interest and taxes relative to total revenue. For Anika Therapeutics (ANIK), this metric reflects the efficiency of commercializing hyaluronic acid-based products. By analyzing the operating profit margin history, an investor assesses the sustainability of cash flow. High FDA barriers and protected distribution channels allow the company to maintain pricing power. Stable growth in this metric confirms the fundamental reliability of the capital.

Competitors of Anika Therapeutics (ANIK)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|Stereotaxis Inc (STXS) - Operating Profitability|Return on Sales by Operating Profit STIM|SGHT (Sight Sciences Inc) - Operating Margin|OBIO: Operating Profit Rate|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)